Healthequity Historical Income Statement


USD 57.67  3.72  6.06%   

Historical analysis of Healthequity income statement accounts such as Gross Profit of 457.2 M or Interest Expense of 39.5 M can show how well Healthequity performed in making a profits. Evaluating Healthequity income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Healthequity's future profits or losses. Financial Statement Analysis is much more than just reviewing and examining Healthequity latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Healthequity is a good buy for the upcoming year.
Please check Risk vs Return Analysis.

Healthequity Net Income

(45.45 Million)


About Healthequity Income Statement Analysis

Healthequity Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Healthequity shareholders. The income statement also shows Healthequity investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Healthequity Income Statement Chart

Healthequity Income Statement is one of the three primary financial statements used for reporting Healthequity's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Healthequity revenue and expense. Healthequity Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Healthequity Direct Expenses is fairly stable at the moment as compared to the past year. Healthequity reported Direct Expenses of 332.85 Million in 2021. Cost of Revenue is likely to rise to about 359.1 M in 2022, whereas Consolidated Income is likely to drop (45.5 M) in 2022.

Consolidated Income

The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of Net Income to Non Controlling Interests.

Earning Before Interest and Taxes EBIT

Earnings Before Interest and Tax is calculated by adding Income Tax Expense and Interest Expense back to Net Income.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Healthequity financial statement analysis. It represents the amount of money remaining after all of Healthequity operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.


Revenues refers to the total amount of money received by Healthequity for goods sold or services provided during a certain time period. It also includes all of Healthequity sales as well as any other increase in Healthequity equity.Revenues are reported on Healthequity income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold; services rendered; insurance premiums; or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.
Most accounts from Healthequity income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Healthequity current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please check Risk vs Return Analysis.Healthequity Direct Expenses is fairly stable at the moment as compared to the past year. Healthequity reported Direct Expenses of 332.85 Million in 2021. Cost of Revenue is likely to rise to about 359.1 M in 2022, whereas Consolidated Income is likely to drop (45.5 M) in 2022.
 2019 2020 2021 2022 (projected)
Interest Expense24.77 M34.88 M36.57 M39.46 M
Gross Profit325.91 M415.33 M423.71 M457.16 M

Healthequity income statement Correlations

Healthequity Account Relationship Matchups

Healthequity income statement Accounts

201720182019202020212022 (projected)
Direct Expenses94.61 M106.05 M206.08 M318.24 M332.85 M359.13 M
Consolidated Income47.36 M73.9 M39.66 M8.83 M(44.29 M)(45.45 M)
Cost of Revenue94.61 M106.05 M206.08 M318.24 M332.85 M359.13 M
Earning Before Interest and Taxes EBIT52.46 M76.09 M67.93 M39.02 M(30.17 M)(30.96 M)
Earning Before Interest and Taxes USD52.46 M76.09 M67.93 M39.02 M(30.17 M)(30.96 M)
Gross Profit134.92 M181.19 M325.91 M415.33 M423.71 M457.16 M
Net Income47.36 M73.9 M39.66 M8.83 M(44.29 M)(45.45 M)
Net Income Common Stock47.36 M73.9 M39.66 M8.83 M(44.29 M)(45.45 M)
Net Income Common Stock USD47.36 M73.9 M39.66 M8.83 M(44.29 M)(45.45 M)
Operating Expenses80.5 M103.52 M248.9 M381.32 M447.94 M483.31 M
Operating Income54.42 M77.67 M77.01 M34.01 M(24.24 M)(24.88 M)
Revenues229.53 M287.24 M531.99 M733.57 M756.56 M816.28 M
Revenues USD229.53 M287.24 M531.99 M733.57 M756.56 M816.28 M
Research and Development Expense27.39 M35.06 M77.58 M124.81 M157.36 M169.79 M
Selling General and Administrative Expense48.25 M62.54 M104.51 M134.46 M142.98 M154.27 M
Weighted Average Shares60.3 M61.84 M67.03 M74.23 M83.13 M72.91 M
Weighted Average Shares Diluted61.85 M63.37 M68.45 M75.68 M83.13 M76.54 M
Income Tax Expense4.83 M1.92 M3.49 M(4.69 M)(22.45 M)(23.04 M)

Be your own money manager

Our tools can tell you how much better you can do entering a position in Healthequity without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bond Analysis Now


Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Risk vs Return Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
4.9 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.